GB0003228D0 - Treatment of GI disorders - Google Patents

Treatment of GI disorders

Info

Publication number
GB0003228D0
GB0003228D0 GB0003228A GB0003228A GB0003228D0 GB 0003228 D0 GB0003228 D0 GB 0003228D0 GB 0003228 A GB0003228 A GB 0003228A GB 0003228 A GB0003228 A GB 0003228A GB 0003228 D0 GB0003228 D0 GB 0003228D0
Authority
GB
United Kingdom
Prior art keywords
disorders
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0003228A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmagene Laboratories Ltd
Original Assignee
Pharmagene Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmagene Laboratories Ltd filed Critical Pharmagene Laboratories Ltd
Priority to GB0003228A priority Critical patent/GB0003228D0/en
Publication of GB0003228D0 publication Critical patent/GB0003228D0/en
Priority to ES00949718T priority patent/ES2208382T3/en
Priority to EP00949718A priority patent/EP1200093B1/en
Priority to AT00949718T priority patent/ATE250417T1/en
Priority to CA002378710A priority patent/CA2378710A1/en
Priority to JP2001513398A priority patent/JP2004500333A/en
Priority to PCT/GB2000/002907 priority patent/WO2001008668A2/en
Priority to GB0204118A priority patent/GB2368524B/en
Priority to DE60005526T priority patent/DE60005526T2/en
Priority to AU62993/00A priority patent/AU776149B2/en
Ceased legal-status Critical Current

Links

GB0003228A 1999-07-30 2000-02-11 Treatment of GI disorders Ceased GB0003228D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB0003228A GB0003228D0 (en) 2000-02-11 2000-02-11 Treatment of GI disorders
AU62993/00A AU776149B2 (en) 1999-07-30 2000-07-28 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of GI disorders
CA002378710A CA2378710A1 (en) 1999-07-30 2000-07-28 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders
EP00949718A EP1200093B1 (en) 1999-07-30 2000-07-28 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders
AT00949718T ATE250417T1 (en) 1999-07-30 2000-07-28 USE OF 2-AMINO-4-(4-FLUORONAPHTH-1-YL)-6- ISOPROPYLPYRIMIDINES FOR THE TREATMENT OF DISEASES OF THE GASTROINTESTINAL TRACT
ES00949718T ES2208382T3 (en) 1999-07-30 2000-07-28 USE OF 2-AMINO-4- (4-FLUORONAFT-1-IL) -6-ISOPROPILPIRAMIDINA IN THE TREATMENT OF GASTROINTESTINAL ALTERATIONS.
JP2001513398A JP2004500333A (en) 1999-07-30 2000-07-28 Use of 2-amino-4- (4-fluoronaphth-1-yl) -6-isopropylpyrimidine in the treatment of gastrointestinal tract disorders
PCT/GB2000/002907 WO2001008668A2 (en) 1999-07-30 2000-07-28 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders
GB0204118A GB2368524B (en) 1999-07-30 2000-07-28 Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders
DE60005526T DE60005526T2 (en) 1999-07-30 2000-07-28 USE OF 2-AMINO-4- (4-FLUORONAPHTH-1-YL) -6-ISOPROPYLPYRIMIDINE FOR THE TREATMENT OF DISEASES OF THE STOMESTYLE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0003228A GB0003228D0 (en) 2000-02-11 2000-02-11 Treatment of GI disorders

Publications (1)

Publication Number Publication Date
GB0003228D0 true GB0003228D0 (en) 2000-04-05

Family

ID=9885461

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0003228A Ceased GB0003228D0 (en) 1999-07-30 2000-02-11 Treatment of GI disorders

Country Status (1)

Country Link
GB (1) GB0003228D0 (en)

Similar Documents

Publication Publication Date Title
GB0007193D0 (en) Treatment of movrmrnt disorders
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
IL161267A0 (en) Combinations for the treatment of immunoinflammatory disorders
HUP0300347A3 (en) Improved treatment of neovascularization
IL155433A0 (en) Treatment of t cell disorders
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
GB0001710D0 (en) Therapeutic treatment
HRP20020729A2 (en) Treatment of psoriasis
IL155874A0 (en) Treatment of anxiety disorders
AU2096002A (en) Therapeutic treatment
GB2381455B (en) Treatment of burns
GB0003228D0 (en) Treatment of GI disorders
EP1303281A4 (en) Methods of treatment
AU3582101A (en) The treatment of functional gastrointestinal disorders
GB0010496D0 (en) Treatment of conditions of the central nervous system
IL153788A0 (en) Treatment of eating disorders using carboxyalkylethers
GB0017951D0 (en) Treatment of movement disorders
GB0021060D0 (en) Treatment of functional gastrointestinal disorders
GB0004998D0 (en) The treatment of functional gastrointestinal disorders
GB0013928D0 (en) Methods of treatment
GB0014904D0 (en) Methods of treatment
GB0219811D0 (en) Treatment of excreta
GB0029955D0 (en) Treatment of neuropsychiatric disorders
AU6191201A (en) Treatment of effluent

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)